Distribution of Genomically Defined Recurrence Risk in Luminal A and B Breast Tumors Defined by Inmunohistochemistry: A Retrospective Study in Spanish Population

Disclosure: H. Gogas: Advisory or consultancy role: Amgen, Bristol-Myers Squibb, MSD, Novartis, Roche. C. Papandreou: Honoraria and/or Advisory Role: Astellas Pharmaceuticals, AstraZeneca, Janssen Pharmaceutical, Merck S.A., Roche (Hellas) S.A., Sanofi-Aventis, Pfizer Hellas S.A., Merck Sharp & Dohme. G. Fountzilas: Honoraria: AstraZeneca. Consulting or Advisory Role: Pfizer, Sanofi, Roche. Stock ownership (an immediate family member): Ariad. All other authors have declared no conflicts of interest.